Skip to main content


Log in

Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience

  • Original Article
  • Published:
Radiation Medicine Aims and scope Submit manuscript



The aim of this study was to assess the feasibility and effectiveness of magnetic resonance (MRI)-guided focused ultrasound (MRIgFUS) ablation for uterine fibroids and to identify the candidates for this treatment.

Materials and methods

A total of 48 patients with a symptomatic uterine fibroid underwent MRIgFUS. The percent ablation volume was calculated, and the patients’ characteristics and the MR imaging features of the fibroids that might predict the effect of this treatment were assessed. Changes in the symptoms related to the uterine fibroid were assessed at 6 and 12 months.


The planned target zone were successfully treated in 32 patients with bulk-related and menstrual symptoms but unsuccessfully treated in the remaining 16 patients. These 16 patients were obese or their uterine fibroid showed heterogeneous high signal intensity on T2-weighted images. The 32 successfully treated patients were followed up for 6 months. At the 6-month follow-up, bulk-related and menstrual symptoms were diminished in 60% and 51% of patients, respectively. Among them, 17 patients were followed up for 12 months, and 9 of them who showed alleviation of bulk-related symptoms at 6 months had further improvement. The mean percent ablation volume of those nine patients was 51%. In 5 (33%) of the 15 patients with alleviation of menstrual symptoms at 6 months, the symptoms became worse at 12 months. There was a significant difference in the mean percent ablation volume between patients with alleviation of menstrual symptoms and those without (54% vs. 37%; P = 0.03).


MRIgFUS ablation is a safe, effective treatment for nonobese patients with symptomatic fibroids that show low signal intensity on T2-weighted images. Ablation of more than 50% of the fibroid volume may be needed with a short-term follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  1. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997;90:967–973.

    Article  PubMed  CAS  Google Scholar 

  2. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol 1990;97:285–298.

    PubMed  CAS  Google Scholar 

  3. Benagiano G, Morini A, Primiero FM. Fibroids: overview of current and future treatment options. Br J Obstet Gynaecol 1992;99:18–22.

    PubMed  Google Scholar 

  4. Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med 1993;328:856–860.

    Article  PubMed  CAS  Google Scholar 

  5. Tulandi T, al-Took S. Endoscopic myomectomy: laparoscopic and hysteroscopy. Obstet Gynecol Clin North Am 1999;26:135–148.

    Article  PubMed  CAS  Google Scholar 

  6. Cowan BD, Sewell PE, Howard JC, Arriola RM, Robinette LG. Interventional magnetic resonance imaging cryotherapy of uterine fibroid tumors: preliminary observation. Am J Obstet Gynecol 2002;186:1183–1187.

    Article  PubMed  Google Scholar 

  7. Law P, Gedroyc WM, Regan L. Magnetic resonance guided percutaneous laser ablation of uterine fibroids. Lancet 1999;354:2049–2050.

    Article  PubMed  CAS  Google Scholar 

  8. Ravina JH, Herbreteau D, Ciaru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolization to treat uterine myomata. Lancet 1995;346:671–672.

    Article  PubMed  CAS  Google Scholar 

  9. Pelage JP, Dref OL, Soyer P, Kardache M, Dahan H, Abitbol M, et al. Fibroid-related menorrhagia: treatment with super-selective embolization of the uterine arteries and midterm follow-up. Radiology 2000;215:428–431.

    PubMed  CAS  Google Scholar 

  10. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003;226:897–905.

    Article  PubMed  Google Scholar 

  11. Stewart EA, Gedroyc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003;189:48–54.

    Article  PubMed  Google Scholar 

  12. Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynynen K, et al. MR guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 2004;183:1713–1719.

    PubMed  Google Scholar 

  13. Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gastout B, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006;85:22–29.

    Article  PubMed  Google Scholar 

  14. Fennessy FM, Tempany CM, McDannold NJ, Minna JS, Gina H, Gostout B, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery—results of different treatment protocols. Radiology 2007;243:885–893.

    Article  PubMed  Google Scholar 

  15. Elizabeth KA, Neil MK, Ame NR, Robert JM. Features Influencing patient selection for fibroid treatment with magnetic resonance-guided focused ultrasound. J Vasc Interv Radiol 2007;18:681–685.

    Article  Google Scholar 

  16. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284:3043–3045.

    Google Scholar 

  17. Kuroda K, Chung A, Hynynen K, Jolesz FA. Calibration of water proton chemical shift with temperature for noninvasive temperature imaging during focused ultrasound surgery. J Magn Reson Imaging 1998;8:175–181.

    Article  PubMed  CAS  Google Scholar 

  18. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002;99:290–300.

    Article  PubMed  Google Scholar 

  19. Ueda H, Togashi K, Konishi I, Kataoka ML, Koyama T, Fujiwara T, et al. Unusual appearances of uterine leiomyomas: mr imaging findings and their histopathologic backgrounds. Radiographics 1999;19:131–145.

    Google Scholar 

  20. Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M, et al. The Fibroid Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005;106:1309–1318.

    PubMed  Google Scholar 

  21. Hovsepian DM, Siskin GP, Bonn J, Cardella JF, Clark TW, Lampmann LE, et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol 2004;15:535–541.

    PubMed  Google Scholar 

  22. Katsumori T, Nakajima K, Tokuhiro M. Gadolinium-enhanced MR imaging in the evaluation of uterine fibroids treated with uterine artery embolization AJR Am J Roentgenol 2001;177:303–307.

    CAS  Google Scholar 

  23. Pelage JP, Guaou NG, Jha RC, Ascher SM, Spies JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology 2004;230:803–809.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Koji Mikami.

About this article

Cite this article

Mikami, K., Murakami, T., Okada, A. et al. Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience. Radiat Med 26, 198–205 (2008).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

Key words